Gabriela Kania

This study identifies molecular changes in right ventricular tissue from DCM patients, showing that pulmonary pressure load drives transcriptional remodelling and fibrosis, while proteomic changes reflect immune activation and metabolic shifts.

This study identifies dysferlin as an antifibrotic regulator that limits fibroblast differentiation and myocardial fibrosis in heart failure.

This study shows lanifibranor reduces TGF-β1-induced cardiac fibrosis and improves cardiomyocyte function in human models.

This paper shows that elafibranor reduces TGF-β1-induced cardiac fibrosis by improving redox-metabolic and bioenergetic processes in human cardiac models.

This study compares two culture systems for mouse living myocardial slices, finding the biomimetic system provides better viability, structure, and function for cardiac fibrosis research.

The paper analyzes scRNAseq data from multiple tissues to identify shared and tissue-specific myeloid and stromal cell populations in health and disease.